E Fund Management Co., Ltd. Adma Biologics, Inc. Transaction History
E Fund Management Co., Ltd.
- $1.97 Billion
- Q4 2024
A detailed history of E Fund Management Co., Ltd. transactions in Adma Biologics, Inc. stock. As of the latest transaction made, E Fund Management Co., Ltd. holds 36,469 shares of ADMA stock, worth $618,149. This represents 0.03% of its overall portfolio holdings.
Number of Shares
36,469
Previous 25,118
45.19%
Holding current value
$618,149
Previous $502,000
24.5%
% of portfolio
0.03%
Previous 0.03%
Shares
10 transactions
Others Institutions Holding ADMA
# of Institutions
323Shares Held
190MCall Options Held
917KPut Options Held
91.6K-
Black Rock Inc. New York, NY18.6MShares$316 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.1MShares$307 Million0.01% of portfolio
-
State Street Corp Boston, MA13MShares$220 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA12.6MShares$214 Million0.05% of portfolio
-
Morgan Stanley New York, NY8.6MShares$146 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.33B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...